出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年5月
Electronic Skin Patch Market – Global Forecast to 2029
電子スキンパッチ市場 : タイプ (モニタリングと診断、治療)、ワイヤレス接続 (接続、非接続)、用途 (糖尿病管理、心血管モニタリング、温度検知)、エンドユーザー＆地域別 – 2029年までの世界予測
Electronic Skin Patch Market by Type (Monitoring & Diagnostic, Therapeutic), Wireless Connectivity (Connected, Non-connected), Application (Diabetes Management, Cardiovascular Monitoring, Temperature Sensing), End User and Region – Global Forecast to 2029
| ページ数 | 284 |
| 図表数 | 247 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
[myphp file=”contact”] 出版社・価格・納期について
Report Overview
The Electronic Skin Patch market is projected to grow from USD 15.0 billion in 2024 and is projected to reach USD 27.0 billion by 2029; it is expected to grow at a CAGR of 12.5% from 2024 to 2029.
電子スキンパッチ市場は、2024 年の 150 億米ドルから成長し、2029 年までに 270 億米ドルに達すると予測されています。 2024 年から 2029 年にかけて 12.5% の CAGR で成長すると予想されています。
Rising geriatric population, Rapid advancements in flexible electronics, sensors and wireless technologies, and Increasing application beyond traditional healthcare to fuel the growth of Electronic Skin Patch market.
“Market for Monitoring & Diagnostic to hold the largest share during the forecast period.”
Recent innovations have led to integrating multiple sensors within a single patch, enabling the simultaneous monitoring of vital signs and biomarkers. The applications of electronic skin patches for diagnosis and monitoring are vast and diverse, covering various healthcare settings and medical conditions. In critical care settings, such as ICUs these patches continuously monitor vital signs such as heart rate, blood pressure, respiratory rate, and temperature. Dexcom’s continuous glucose monitoring (CGM) system, such as the Dexcom G7, is a crucial tool for diabetes management. This application of electronic skin patches enables individuals with diabetes to continuously monitor their blood glucose levels, eliminating the need for frequent finger pricks.
“Market for Connected electronic skin patches holds for largest market share during the forecast period.”
Connected electronic skin patches leverage wireless technologies, such as BLE, Wi-Fi, cellular connectivity, RF technology, Ethernet, and near-field communication, to transmit real-time data collected by integrated sensors to receiving devices, such as smartphones, smartwatches, or medical consoles. These patches enable continuous monitoring of vital signs and other health metrics, including glucose levels, heart rate, blood pressure, and temperature. This real-time data transmission provides healthcare professionals with up-to-date information about the patient’s health status, facilitating timely intervention for critical situations and enabling remote patient monitoring from a distance. Additionally, the energy efficiency of BLE technology makes it particularly suitable for wearable devices, such as electronic skin patches, ensuring long battery life and uninterrupted monitoring.
“Market for Cardiovascular Monitoring holds for second largest market share during the forecast period.”
Electronic skin patches for cardiovascular monitoring provide a promising solution to this pressing need by enabling continuous and non-invasive monitoring of blood pressure, heart rate, and electrocardiogram (ECG) readings. One of the most significant applications of these patches is in electrocardiogram (ECG) monitoring. Patches equipped with ECG sensors, such as AliveCor’s KardiaMobile, allow individuals to record their heart rhythm at any time, enabling early detection of potential arrhythmias, such as atrial fibrillation, which can cause serious health consequences. Additionally, these patches can be used to track heart rate variability (HRV), a valuable indicator of overall cardiovascular health and stress levels. Beyond ECG, electronic skin patches can monitor vital signs essential for cardiovascular health assessment. Patches, such as Philips PatchPoint, offer continuous monitoring of blood oxygen levels, heart rate, blood pressure.
“Market for Healthcare segment is projected to hold for largest share during the forecast timeline.”
The healthcare industry accounts for major share in electronic skin patch market. The healthcare industry is further segmented into hospitals & clinics, home care/home diagnostics, and diagnostics laboratories. The market is driven with the increasing demand for connected devices with more advanced features and functionalities. The low-cost, disposable, body-worn electronic skin patches play a significant role in monitoring several physiological parameters that can be analyzed remotely to keep track of critical health indicators of patients and check whether they have taken their medication. Wearable patches replace various clinical devices, offering comfort and convenience to patients and healthcare professionals. Remote monitoring and telehealth are emerging concepts in the healthcare industry. Healthcare service providers are adopting electronic skin patches and wireless technologies to improve their relationship with patients. This would reduce the number of hospital visits of patients and bring down the cost of patient care. Sensor patches and related healthcare services continue to improve with better compliance and enhanced security and privacy features.
“North America is expected to have the largest market share during the forecast period.”
North America presents promising growth prospects driven by the strong emphasis on self-care and health monitoring, alongside its well-established healthcare infrastructure and commitment to technological progress. The increasing penetration of mobile devices (smartphones, tablets, and PDAs) and the growing popularity of wearables are driving the demand for electronic skin patches. Consumers are aware of new technologies and capabilities of electronic skin patches and are early adopters of new technologies. In addition, consumers seek new and innovative skin patches for monitoring fitness. These factors are major contributors to the growth of the electronic skin patch market in the region.
Extensive primary interviews were conducted with key industry experts in the Electronic Skin Patch market space to determine and verify the market size for various segments and subsegments gathered through secondary research. The break-up of primary participants for the report has been shown below:
The break-up of the profile of primary participants in the Electronic Skin Patch market:
- By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25%
- By Designation: C Level – 45%, Director Level – 35%, Others-20%
- By Region: North America – 40%, Europe – 23%, Asia Pacific – 30%, ROW- 7%
The report profiles key players in the Electronic Skin Patch market with their respective market ranking analysis. Prominent players profiled in this report are Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics Ltd. (US), Active Environmental Solutions (Australia), among others.
Apart from this, ScottCare (US), VivaLNK, Inc. (US), Bittium (Finland), Cardiomo (US), Seers Technology (South Korea), SIGKNOW (Taiwan), Cortrium (Denmark), Qardio, Inc. (US), LifeSignals (US), Blue Spark Technologies, Inc. (US), Epicore Biosystems (US), HIVOX BIOTEK INC. (US), IontoPatch (US)., are among a few emerging companies in the Electronic Skin Patch market.
Research Coverage:
This research report categorizes the Electronic Skin Patch market based on Type, Wireless Connectivity, Application, End User, and region. The report describes the major drivers, restraints, challenges, and opportunities pertaining to the Electronic Skin Patch market and forecasts the same till 2029. Apart from these, the report also consists of leadership mapping and analysis of all the companies included in the Electronic Skin Patch ecosystem.
Key Benefits of Buying the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Electronic Skin Patch Market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (Increasing burden of chronic diseases, Surging demand for remote health monitoring solutions, Rising geriatric population, Rapid advancements in flexible electronics, sensors and wireless technologies) influencing the growth of the Electronic Skin Patch market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Electronic Skin Patch market.
• Market Development: Comprehensive information about lucrative markets – the report analysis the Electronic Skin Patch Market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Electronic Skin Patch Market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation among others in the Electronic Skin Patch Market.
Table of Contents
1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.3 STUDY SCOPE 32
1.3.1 INCLUSIONS AND EXCLUSIONS 32
1.3.2 MARKETS COVERED 32
FIGURE 1 ELECTRONIC SKIN PATCH MARKET SEGMENTATION 32
1.3.3 REGIONAL SCOPE 33
1.3.4 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 UNITS CONSIDERED 34
1.6 LIMITATIONS 34
1.7 STAKEHOLDERS 34
1.8 IMPACT OF RECESSION 34
FIGURE 2 GDP DECLINE IN MAJOR ECONOMIES, 2021–2023 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 3 ELECTRONIC SKIN PATCH MARKET: RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 List of key secondary sources 37
2.1.1.2 Key data from secondary sources 38
2.1.2 PRIMARY DATA 38
2.1.2.1 List of primary interview participants 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Key industry insights 39
2.1.2.4 Breakdown of primaries 40
2.1.3 SECONDARY AND PRIMARY RESEARCH 40
2.2 MARKET SIZE ESTIMATION METHODOLOGY 41
FIGURE 4 ELECTRONIC SKIN PATCH MARKET: RESEARCH FLOW 42
2.2.1 BOTTOM-UP APPROACH 42
2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side) 42
FIGURE 5 ELECTRONIC SKIN PATCH MARKET: BOTTOM-UP APPROACH 43
2.2.2 TOP-DOWN APPROACH 43
2.2.2.1 Approach to arrive at market size using top-down analysis (supply side) 43
FIGURE 6 ELECTRONIC SKIN PATCH MARKET: TOP-DOWN APPROACH 44
FIGURE 7 ELECTRONIC SKIN PATCH MARKET SIZE ESTIMATION METHODOLOGY (SUPPLY SIDE) 44
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 8 ELECTRONIC SKIN PATCH MARKET: DATA TRIANGULATION 45
2.4 RESEARCH ASSUMPTIONS 46
FIGURE 9 ELECTRONIC SKIN PATCH MARKET: RESEARCH ASSUMPTIONS 46
2.5 RISK ASSESSMENT 47
TABLE 1 ELECTRONIC SKIN PATCH MARKET: RISK ASSESSMENT 47
2.6 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET 47
TABLE 2 PARAMETERS CONSIDERED TO ANALYZE RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET 47
2.7 RESEARCH LIMITATIONS 48
FIGURE 10 ELECTRONIC SKIN PATCH MARKET: RESEARCH LIMITATIONS 48
3 EXECUTIVE SUMMARY 49
FIGURE 11 MONITORING & DIAGNOSTIC TO ACCOUNT FOR LARGER MARKET SHARE IN 2024 50
FIGURE 12 CONNECTED SEGMENT TO HOLD LARGER SHARE OF ELECTRONIC SKIN PATCH MARKET IN 2029 51
FIGURE 13 HEALTHCARE TO RECORD HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET, BY END USER, DURING FORECAST PERIOD 51
FIGURE 14 DIABETES MANAGEMENT APPLICATION TO DOMINATE ELECTRONIC SKIN PATCH MARKET BETWEEN 2024 AND 2029 52
FIGURE 15 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD 53
4 PREMIUM INSIGHTS 54
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ELECTRONIC SKIN PATCH MARKET 54
FIGURE 16 INCREASING PREVALENCE OF DIABETES AND CARDIOVASCULAR DISEASES TO CREATE LUCRATIVE OPPORTUNITIES FOR PLAYERS IN ELECTRONIC SKIN PATCH MARKET 54
4.2 ELECTRONIC SKIN PATCH MARKET, BY TYPE 54
FIGURE 17 MONITORING & DIAGNOSTIC SEGMENT TO REGISTER HIGHER CAGR FROM 2024 TO 2029 54
4.3 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY 55
FIGURE 18 CONNECTED SEGMENT TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD 55
4.4 ELECTRONIC SKIN PATCH MARKET, BY END USER 55
FIGURE 19 HEALTHCARE TO DOMINATE ELECTRONIC SKIN PATCH MARKET, BY END USER, DURING FORECAST PERIOD 55
4.5 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION 56
FIGURE 20 DIABETES MANAGEMENT TO HOLD LARGEST SHARE OF ELECTRONIC SKIN PATCH MARKET IN 2024 56
4.6 ELECTRONIC SKIN PATCH MARKET, BY COUNTRY 56
FIGURE 21 ELECTRONIC SKIN PATCH MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 58
FIGURE 22 ELECTRONIC SKIN PATCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
5.2.1 DRIVERS 58
5.2.1.1 Increasing burden of chronic diseases 58
FIGURE 23 NUMBER OF PEOPLE WITH CHRONIC DISEASES IN US 59
5.2.1.2 Surging demand for remote health monitoring solutions 59
5.2.1.3 Rising geriatric population 60
FIGURE 24 PROPORTION OF POPULATION AGED OVER 65 YEARS, 2050 61
5.2.1.4 Rapid advancement in flexible electronics, sensors, and wireless technologies 61
FIGURE 25 IMPACT ANALYSIS: DRIVERS 63
5.2.2 RESTRAINTS 63
5.2.2.1 Data privacy and security issues 63
5.2.2.2 High upfront and production costs 64
FIGURE 26 IMPACT ANALYSIS: RESTRAINTS 64
5.2.3 OPPORTUNITIES 65
5.2.3.1 Rising emphasis on improving accuracy of health monitoring devices 65
5.2.3.2 Expanding applications of electronic skin patches beyond traditional healthcare 65
5.2.3.3 Growing importance of detecting diseases at early stage 66
FIGURE 27 IMPACT ANALYSIS: OPPORTUNITIES 67
5.2.4 CHALLENGES 67
5.2.4.1 Data overload and limited processing power 67
5.2.4.2 Complex regulatory environments 68
FIGURE 28 IMPACT ANALYSIS: CHALLENGES 68
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69
5.4 PRICING ANALYSIS 70
5.4.1 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE 70
FIGURE 30 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023 70
TABLE 3 INDICATIVE PRICE TREND OF KEY PLAYERS, BY TYPE, 2023 71
5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 71
FIGURE 31 AVERAGE SELLING PRICE TREND, BY REGION, 2020–2023 71
5.5 VALUE CHAIN ANALYSIS 72
FIGURE 32 VALUE CHAIN ANALYSIS 72
5.6 ECOSYSTEM ANALYSIS 74
FIGURE 33 ELECTRONIC SKIN PATCH ECOSYSTEM 74
TABLE 4 ROLE OF COMPANIES IN ELECTRONIC SKIN PATCH ECOSYSTEM 75
5.7 INVESTMENT AND FUNDING SCENARIO 76
FIGURE 34 INVESTMENT AND FUNDING SCENARIO, 2019–2023 76
5.8 TECHNOLOGY ANALYSIS 77
5.8.1 KEY TECHNOLOGIES 77
5.8.1.1 Miniaturized sensors 77
5.8.1.2 Biocompatible materials and adhesives 77
5.8.2 COMPLEMENTARY TECHNOLOGIES 78
5.8.2.1 Artificial intelligence (AI) and Internet of Things (IoT) 78
5.8.2.2 Data encryption and security protocols 79
5.8.2.3 Cloud computing 79
5.8.3 ADJACENT TECHNOLOGIES 79
5.8.3.1 Wearable electronics 79
5.8.3.2 Telemedicine 80
5.9 PATENT ANALYSIS 81
TABLE 5 ELECTRONIC SKIN PATCH MARKET: LIST OF PATENTS, 2022–2023 81
FIGURE 35 PATENTS APPLIED AND GRANTED, 2014–2023 85
5.10 TRADE ANALYSIS 86
5.10.1 IMPORT SCENARIO (HS CODE 901890) 86
FIGURE 36 IMPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019–2023 (USD MILLION) 86
5.10.2 EXPORT SCENARIO (HS CODE 901890) 87
FIGURE 37 EXPORT DATA FOR HS CODE 901890-COMPLIANT INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2019–2023 (USD MILLION) 87
5.11 KEY CONFERENCES AND EVENTS, 2024–2025 88
TABLE 6 ELECTRONIC SKIN PATCH MARKET: LIST OF CONFERENCES AND EVENTS, 2024–2025 88
5.12 CASE STUDY ANALYSIS 90
5.12.1 COVESTRO ENABLES EFFECTIVE MONITORING OF VITAL SIGNS AND HEALTH PARAMETERS USING SENSOR-BASED WEARABLE PATCHES 90
5.12.2 DUPONT ADDRESSES LONG-TERM MONITORING CHALLENGES WITH NIGHTHAWK SMART PATCHES 90
5.12.3 MEDHERANT ENSURES ENHANCED DRUG DELIVERY BY LEVERAGING TEPI PATCH TECHNOLOGY 91
5.12.4 NANOTECH SOLUTIONS ENABLES USERS ACHIEVE HIGH SENSIVITY AND SPECIFICITY USING ADVANCED PATCHES EQUIPPED WITH NANOMATERIAL-BASED SENSORS 91
5.12.5 TAPE CONVERTERS HOLLAND B.V. ENABLES CONTINUOUS MONITORING OF HYDRATION LEVELS WITH SMART PATCHES 92
5.13 REGULATORY LANDSCAPE 92
5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 8 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 10 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.13.2 STANDARDS 96
TABLE 11 NORTH AMERICA: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES 96
TABLE 12 EUROPE: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES 96
TABLE 13 ASIA PACIFIC: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES 97
TABLE 14 ROW: SAFETY STANDARDS FOR ELECTRONIC SKIN PATCHES 97
5.14 PORTER’S FIVE FORCES ANALYSIS 98
FIGURE 38 PORTER’S FIVE FORCES ANALYSIS 98
5.14.1 THREAT OF NEW ENTRANTS 99
5.14.2 THREAT OF SUBSTITUTES 99
5.14.3 BARGAINING POWER OF SUPPLIERS 99
5.14.4 BARGAINING POWER OF BUYERS 99
5.14.5 INTENSITY OF COMPETITIVE RIVALRY 100
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 100
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 100
FIGURE 39 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 100
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%) 101
5.15.2 BUYING CRITERIA 101
FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 101
TABLE 16 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 101
6 ELECTRONIC SKIN PATCH MARKET, BY TYPE 102
6.1 INTRODUCTION 103
TABLE 17 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION) 103
TABLE 18 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (USD MILLION) 104
TABLE 19 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (MILLION UNITS) 104
TABLE 20 ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (MILLION UNITS) 104
FIGURE 41 MONITORING & DIAGNOSTIC TO DOMINATE MARKET, BY TYPE, DURING FORECAST PERIOD 105
6.2 MONITORING & DIAGNOSTIC 105
6.2.1 RAPID ADVANCEMENT IN SENSOR TECHNOLOGY TO ACCELERATE SEGMENTAL GROWTH 105
TABLE 21 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 107
TABLE 22 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 107
TABLE 23 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 108
TABLE 24 MONITORING & DIAGNOSTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 108
6.3 THERAPEUTIC 108
6.3.1 REQUIREMENT FOR PRECISE MONITORING OF PATIENTS WITH CARDIOVASCULAR DISEASES TO BOOST SEGMENTAL GROWTH 108
TABLE 25 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 110
TABLE 26 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 110
TABLE 27 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 110
TABLE 28 THERAPEUTIC: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 110
7 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY 111
7.1 INTRODUCTION 112
TABLE 29 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION) 112
TABLE 30 ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION) 113
FIGURE 42 CONNECTED SEGMENT TO ACCOUNT FOR LARGER MARKET SHARE IN 2029 113
7.2 CONNECTED 113
7.2.1 RAPID INNOVATION IN AI AND IOT TECHNOLOGIES TO CONTRIBUTE TO SEGMENTAL GROWTH 113
TABLE 31 CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 115
TABLE 32 CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 115
7.3 NON-CONNECTED 115
7.3.1 ENFORCEMENT OF REGULATIONS TO SAFEGUARD PATIENT HEALTH INFORMATION TO FACILITATE SEGMENTAL GROWTH 115
TABLE 33 NON-CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 117
TABLE 34 NON-CONNECTED: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 117
8 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 35 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 119
TABLE 36 ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 120
FIGURE 43 DIABETES MANAGEMENT APPLICATION TO HOLD LARGEST MARKET SHARE IN 2029 120
8.2 DIABETES MANAGEMENT 121
8.2.1 PREFERENCE FOR NON-INVASIVE AND CONTINUOUS GLUCOSE MONITORING SYSTEMS TO DRIVE MARKET 121
TABLE 37 DIABETES MANAGEMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 122
TABLE 38 DIABETES MANAGEMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 122
8.3 CARDIOVASCULAR MONITORING 122
8.3.1 REQUIREMENT FOR TIMELY INTERVENTION AND TREATMENT OF HEART DISEASES TO FUEL SEGMENTAL GROWTH 122
TABLE 39 CARDIOVASCULAR MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 124
TABLE 40 CARDIOVASCULAR MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 124
8.4 GENERAL PATIENT MONITORING 124
8.4.1 USE OF REMOTE MONITORING SOLUTIONS TO DETECT EARLY WARNING SIGNS TO BOOST SEGMENTAL GROWTH 124
TABLE 41 GENERAL PATIENT MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 125
TABLE 42 GENERAL PATIENT MONITORING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 126
8.5 TEMPERATURE SENSING 126
8.5.1 ADOPTION OF SKIN PATCHES TO PREVENT HYPOTHERMIA AND HYPERTHERMIA IN PRETERM INFANTS TO PROPEL MARKET 126
TABLE 43 TEMPERATURE SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 127
TABLE 44 TEMPERATURE SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 127
8.6 ELECTRICAL STIMULATION 127
8.6.1 USE OF NON-INVASIVE DEVICES IN CHRONIC PAIN AND MUSCULOSKELETAL CONDITION MANAGEMENT TO BOOST SEGMENTAL GROWTH 127
TABLE 45 ELECTRICAL STIMULATION: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 128
TABLE 46 ELECTRICAL STIMULATION: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 128
8.7 IONTOPHORESIS 129
8.7.1 PREFERENCE FOR ONE-STEP DRUG ADMINISTRATION FOR TREATING INFLAMMATION TO AUGMENT SEGMENTAL GROWTH 129
TABLE 47 IONTOPHORESIS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 130
TABLE 48 IONTOPHORESIS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 130
8.8 SWEAT SENSING 130
8.8.1 USE OF ADVANCED MONITORING SYSTEMS BY ATHLETES AND FITNESS ENTHUSIASTS TO CONTRIBUTE TO SEGMENTAL GROWTH 130
TABLE 49 SWEAT SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 131
TABLE 50 SWEAT SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 131
8.9 WOUND MONITORING & TREATMENT 131
8.9.1 IMPLEMENTATION OF ADVANCED TECHNOLOGIES TO TREAT CHRONIC WOUNDS TO BOOST SEGMENTAL GROWTH 131
TABLE 51 WOUND MONITORING & TREATMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 132
TABLE 52 WOUND MONITORING & TREATMENT: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 132
8.10 MOTION SENSING 133
8.10.1 IMPLEMENTATION OF REMOTE MONITORING AND TELEHEALTH INITIATIVES TO CONTRIBUTE TO SEGMENTAL GROWTH 133
TABLE 53 MOTION SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 133
TABLE 54 MOTION SENSING: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 134
8.11 OTHER APPLICATIONS 134
TABLE 55 OTHER APPLICATIONS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 135
TABLE 56 OTHER APPLICATIONS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 135
9 ELECTRONIC SKIN PATCH MARKET, BY END USER 136
9.1 INTRODUCTION 137
TABLE 57 ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020–2023 (USD MILLION) 137
TABLE 58 ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024–2029 (USD MILLION) 137
FIGURE 44 HEALTHCARE SEGMENT TO DOMINATE ELECTRONIC SKIN PATCH MARKET BETWEEN 2024 AND 2029 138
9.2 HEALTHCARE 138
TABLE 59 ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, 2020–2023 (USD MILLION) 138
TABLE 60 ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, 2024–2029 (USD MILLION) 139
FIGURE 45 HOME CARE SEGMENT TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET, BY HEALTHCARE, DURING FORECAST PERIOD 139
TABLE 61 HEALTHCARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 139
TABLE 62 HEALTHCARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 140
9.2.1 HOSPITALS & CLINICS 140
9.2.1.1 Growing emphasis on preventive healthcare for patients with cardiovascular diseases to drive market 140
TABLE 63 HOSPITALS & CLINICS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 141
TABLE 64 HOSPITALS & CLINICS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 141
9.2.2 HOME CARE 142
9.2.2.1 Increasing need for remote monitoring of geriatric population susceptible to chronic diseases to foster segmental growth 142
TABLE 65 HOME CARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 143
TABLE 66 HOME CARE: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 143
9.2.3 DIAGNOSTIC LABORATORIES 143
9.2.3.1 Rising burden of cancer to contribute to segmental growth 143
TABLE 67 DIAGNOSTIC LABORATORIES: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 144
TABLE 68 DIAGNOSTIC LABORATORIES: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 144
9.3 FITNESS & SPORTS 145
9.3.1 INCREASING AWARENESS OF MONITORING PHYSIOLOGICAL PARAMETERS AMONG ATHLETES TO PROPEL MARKET 145
TABLE 69 FITNESS & SPORTS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 146
TABLE 70 FITNESS & SPORTS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 146
9.4 OTHER END USERS 147
TABLE 71 OTHER END USERS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 148
TABLE 72 OTHER END USERS: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 148
10 ELECTRONIC SKIN PATCH MARKET, BY REGION 149
10.1 INTRODUCTION 150
FIGURE 46 NORTH AMERICA TO HOLD LARGEST MARKET SHARE IN 2029 150
TABLE 73 ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 151
TABLE 74 ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 151
10.2 NORTH AMERICA 151
10.2.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN NORTH AMERICA 152
FIGURE 47 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET SNAPSHOT 153
FIGURE 48 US TO HOLD LARGEST SHARE OF NORTH AMERICAN ELECTRONIC SKIN PATCH MARKET IN 2029 154
TABLE 75 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 154
TABLE 76 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 154
TABLE 77 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION) 155
TABLE 78 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (USD MILLION) 155
TABLE 79 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 155
TABLE 80 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 156
TABLE 81 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION) 156
TABLE 82 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION) 156
TABLE 83 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020–2023 (USD MILLION) 157
TABLE 84 NORTH AMERICA: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024–2029 (USD MILLION) 157
10.2.2 US 157
10.2.2.1 Increasing healthcare expenditure and elderly population to contribute to market growth 157
10.2.3 CANADA 158
10.2.3.1 Surging demand for self-administered drug treatments from chronic disease patients to boost market growth 158
10.2.4 MEXICO 159
10.2.4.1 Rising premature deaths caused by chronic diseases to fuel market growth 159
10.3 EUROPE 160
10.3.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN EUROPE 161
FIGURE 49 EUROPE: ELECTRONIC SKIN PATCH MARKET SNAPSHOT 162
FIGURE 50 UK TO RECORD HIGHEST CAGR IN EUROPEAN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD 163
TABLE 85 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 163
TABLE 86 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 163
TABLE 87 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION) 164
TABLE 88 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (USD MILLION) 164
TABLE 89 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 164
TABLE 90 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 165
TABLE 91 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION) 165
TABLE 92 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION) 165
TABLE 93 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020–2023 (USD MILLION) 166
TABLE 94 EUROPE: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024–2029 (USD MILLION) 166
10.3.2 GERMANY 166
10.3.2.1 Increasing investment in advanced healthcare systems to augment market growth 166
10.3.3 UK 167
10.3.3.1 Growing burden of chronic diseases to contribute to market growth 167
10.3.4 FRANCE 167
10.3.4.1 Rising geriatric population requiring long-term care to drive market 167
10.3.5 REST OF EUROPE 168
10.4 ASIA PACIFIC 169
10.4.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN ASIA PACIFIC 169
FIGURE 51 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET SNAPSHOT 170
FIGURE 52 CHINA TO EXHIBIT HIGHEST CAGR IN MARKET FROM 2024 TO 2029 171
TABLE 95 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 171
TABLE 96 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 171
TABLE 97 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION) 172
TABLE 98 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (USD MILLION) 172
TABLE 99 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 172
TABLE 100 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 173
TABLE 101 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION) 173
TABLE 102 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION) 173
TABLE 103 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020–2023 (USD MILLION) 174
TABLE 104 ASIA PACIFIC: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024–2029 (USD MILLION) 174
10.4.2 CHINA 174
10.4.2.1 Increasing diabetic population and chronic disease prevalence to drive market 174
10.4.3 JAPAN 175
10.4.3.1 Rising government initiative to modernize healthcare facilities to fuel market growth 175
10.4.4 SOUTH KOREA 176
10.4.4.1 Growing medical tourism due to improved healthcare infrastructure to expedite market growth 176
10.4.5 REST OF ASIA PACIFIC 176
10.5 ROW 177
10.5.1 RECESSION IMPACT ON ELECTRONIC SKIN PATCH MARKET IN ROW 177
FIGURE 53 ROW: ELECTRONIC SKIN PATCH MARKET SNAPSHOT 178
FIGURE 54 SOUTH AMERICA TO EXHIBIT HIGHEST CAGR IN ELECTRONIC SKIN PATCH MARKET DURING FORECAST PERIOD 179
TABLE 105 ROW: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2020–2023 (USD MILLION) 179
TABLE 106 ROW: ELECTRONIC SKIN PATCH MARKET, BY REGION, 2024–2029 (USD MILLION) 179
TABLE 107 ROW: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2020–2023 (USD MILLION) 179
TABLE 108 ROW: ELECTRONIC SKIN PATCH MARKET, BY TYPE, 2024–2029 (USD MILLION) 180
TABLE 109 ROW: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2020–2023 (USD MILLION) 180
TABLE 110 ROW: ELECTRONIC SKIN PATCH MARKET, BY APPLICATION, 2024–2029 (USD MILLION) 180
TABLE 111 ROW: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2020–2023 (USD MILLION) 181
TABLE 112 ROW: ELECTRONIC SKIN PATCH MARKET, BY WIRELESS CONNECTIVITY, 2024–2029 (USD MILLION) 181
TABLE 113 ROW: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2020–2023 (USD MILLION) 181
TABLE 114 ROW: ELECTRONIC SKIN PATCH MARKET, BY END USER, 2024–2029 (USD MILLION) 181
10.5.2 SOUTH AMERICA 182
10.5.2.1 Rising disposable income and healthcare spending to contribute to market growth 182
10.5.3 MIDDLE EAST 182
10.5.3.1 Growing emphasis on improving healthcare infrastructure to cater to patients with chronic diseases to support market growth 182
10.5.3.2 GCC countries 182
10.5.3.3 Rest of Middle East 183
TABLE 115 MIDDLE EAST: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2020–2023 (USD MILLION) 183
TABLE 116 MIDDLE EAST: ELECTRONIC SKIN PATCH MARKET, BY COUNTRY, 2024–2029 (USD MILLION) 184
10.5.4 AFRICA 184
10.5.4.1 Increasing implementation of strategies to tackle non-communicable diseases to drive market 184
11 COMPETITIVE LANDSCAPE 185
11.1 OVERVIEW 185
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 185
TABLE 117 ELECTRONIC SKIN PATCH MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020–2024 185
11.3 REVENUE ANALYSIS, 2019–2023 188
FIGURE 55 ELECTRONIC SKIN PATCH MARKET: REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2023 188
11.4 MARKET SHARE ANALYSIS, 2023 188
TABLE 118 ELECTRONIC SKIN PATCH MARKET: DEGREE OF COMPETITION, 2023 189
FIGURE 56 ELECTRONIC SKIN PATCH MARKET SHARE ANALYSIS, 2023 189
11.5 COMPANY VALUATION AND FINANCIAL METRICS 192
FIGURE 57 COMPANY VALUATION 192
FIGURE 58 FINANCIAL METRICS 192
11.6 BRAND/PRODUCT COMPARISON 193
FIGURE 59 BRAND/PRODUCT COMPARISON 193
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 194
11.7.1 STARS 194
11.7.2 EMERGING LEADERS 194
11.7.3 PERVASIVE PLAYERS 194
11.7.4 PARTICIPANTS 194
FIGURE 60 ELECTRONIC SKIN PATCH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 195
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 196
11.7.5.1 Overall footprint 196
FIGURE 61 ELECTRONIC SKIN PATCH MARKET: OVERALL FOOTPRINT 196
11.7.5.2 Type footprint 197
TABLE 119 ELECTRONIC SKIN PATCH MARKET: TYPE FOOTPRINT 197
11.7.5.3 Application footprint 197
TABLE 120 ELECTRONIC SKIN PATCH MARKET: APPLICATION FOOTPRINT 197
11.7.5.4 End user footprint 198
TABLE 121 ELECTRONIC SKIN PATCH MARKET: END USER FOOTPRINT 198
11.7.5.5 Wireless connectivity footprint 199
TABLE 122 ELECTRONIC SKIN PATCH MARKET: WIRELESS CONNECTIVITY FOOTPRINT 199
11.7.5.6 Region footprint 199
TABLE 123 ELECTRONIC SKIN PATCH MARKET: REGION FOOTPRINT 199
11.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 200
11.8.1 PROGRESSIVE COMPANIES 200
11.8.2 RESPONSIVE COMPANIES 200
11.8.3 DYNAMIC COMPANIES 200
11.8.4 STARTING BLOCKS 200
FIGURE 62 ELECTRONIC SKIN PATCH MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 201
11.8.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 202
11.8.5.1 Detailed list of key start-ups/SMEs 202
TABLE 124 ELECTRONIC SKIN PATCH MARKET: LIST OF KEY START-UPS/SMES 202
11.8.5.2 Competitive benchmarking of key start-ups/SMEs 203
TABLE 125 ELECTRONIC SKIN PATCH MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 203
11.9 COMPETITIVE SCENARIO AND TRENDS 204
11.9.1 PRODUCT LAUNCHES 204
TABLE 126 ELECTRONIC SKIN PATCH MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2024 205
11.9.2 DEALS 206
TABLE 127 ELECTRONIC SKIN PATCH MARKET: DEALS, JANUARY 2020–APRIL 2024 206
12 COMPANY PROFILES 208
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
12.1 KEY PLAYERS 208
12.1.1 ABBOTT 208
TABLE 128 ABBOTT: COMPANY OVERVIEW 208
FIGURE 63 ABBOTT: COMPANY SNAPSHOT 209
TABLE 129 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 209
TABLE 130 ABBOTT: PRODUCT LAUNCHES 211
TABLE 131 ABBOTT: DEALS 212
12.1.2 DEXCOM, INC. 215
TABLE 132 DEXCOM, INC.: COMPANY OVERVIEW 215
FIGURE 64 DEXCOM, INC.: COMPANY SNAPSHOT 216
TABLE 133 DEXCOM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 216
TABLE 134 DEXCOM, INC.: PRODUCT LAUNCHES 217
TABLE 135 DEXCOM, INC.: DEALS 219
TABLE 136 DEXCOM, INC.: OTHERS 221
12.1.3 MEDTRONIC 222
TABLE 137 MEDTRONIC: COMPANY OVERVIEW 222
FIGURE 65 MEDTRONIC: COMPANY SNAPSHOT 223
TABLE 138 MEDTRONIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 223
TABLE 139 MEDTRONIC: PRODUCT LAUNCHES 225
TABLE 140 MEDTRONIC: DEALS 226
TABLE 141 MEDTRONIC: OTHERS 227
12.1.4 INSULET CORPORATION 229
TABLE 142 INSULET CORPORATION: COMPANY OVERVIEW 229
FIGURE 66 INSULET CORPORATION: COMPANY SNAPSHOT 230
TABLE 143 INSULET CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 230
TABLE 144 INSULET CORPORATION: PRODUCT LAUNCHES 231
TABLE 145 INSULET CORPORATION: DEALS 231
12.1.5 BOSTON SCIENTIFIC CORPORATION 233
TABLE 146 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 233
FIGURE 67 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 234
TABLE 147 BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 234
TABLE 148 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES 235
TABLE 149 BOSTON SCIENTIFIC CORPORATION: DEALS 236
TABLE 150 BOSTON SCIENTIFIC CORPORATION: OTHERS 237
12.1.6 KONINKLIJKE PHILIPS N.V. 239
TABLE 151 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 239
FIGURE 68 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT 240
TABLE 152 KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 240
TABLE 153 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES 242
TABLE 154 KONINKLIJKE PHILIPS N.V.: DEALS 242
TABLE 155 KONINKLIJKE PHILIPS N.V.: OTHERS 243
12.1.7 BIOLINQ INCORPORATED 244
TABLE 156 BIOLINQ INCORPORATED: COMPANY OVERVIEW 244
TABLE 157 BIOLINQ INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 245
TABLE 158 BIOLINQ INCORPORATED: DEALS 245
12.1.8 ZIO BY IRHYTHM TECHNOLOGIES, INC. 246
TABLE 159 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY OVERVIEW 246
FIGURE 69 ZIO BY IRHYTHM TECHNOLOGIES, INC.: COMPANY SNAPSHOT 247
TABLE 160 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 247
TABLE 161 ZIO BY IRHYTHM TECHNOLOGIES, INC.: PRODUCT LAUNCHES 248
TABLE 162 ZIO BY IRHYTHM TECHNOLOGIES, INC.: DEALS 249
12.1.9 GENTAG, INC. 250
TABLE 163 GENTAG, INC.: COMPANY OVERVIEW 250
TABLE 164 GENTAG, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 251
12.1.10 VITALCONNECT 252
TABLE 165 VITALCONNECT: COMPANY OVERVIEW 252
TABLE 166 VITALCONNECT: PRODUCTS/SOLUTIONS/SERVICES OFFERED 252
TABLE 167 VITALCONNECT: PRODUCT LAUNCHES 253
TABLE 168 VITALCONNECT: DEALS 253
12.1.11 THE SURGICAL COMPANY 255
TABLE 169 THE SURGICAL COMPANY: COMPANY OVERVIEW 255
TABLE 170 THE SURGICAL COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED 255
TABLE 171 THE SURGICAL COMPANY: DEALS 256
TABLE 172 THE SURGICAL COMPANY: EXPANSIONS 257
12.1.12 SENSEONICS LTD. 258
TABLE 173 SENSEONICS LTD.: COMPANY OVERVIEW 258
FIGURE 70 SENSEONICS LTD.: COMPANY SNAPSHOT 259
TABLE 174 SENSEONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 259
TABLE 175 SENSEONICS LTD.: DEALS 260
12.1.13 ACTIVE ENVIRONMENTAL SOLUTIONS 262
TABLE 176 ACTIVE ENVIRONMENTAL SOLUTIONS: COMPANY OVERVIEW 262
TABLE 177 ACTIVE ENVIRONMENTAL SOLUTIONS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 263
12.2 OTHER PLAYERS 264
12.2.1 SCOTTCARE 264
12.2.2 VIVALNK, INC. 265
12.2.3 BITTIUM 266
12.2.4 CARDIOMO 267
12.2.5 SEERS TECHNOLOGY 268
12.2.6 SIGKNOW 269
12.2.7 CORTRIUM 270
12.2.8 QARDIO, INC. 271
12.2.9 LIFESIGNALS 272
12.2.10 BLUE SPARK TECHNOLOGIES, INC. 273
12.2.11 EPICORE BIOSYSTEMS 274
12.2.12 HIVOX BIOTEK INC 275
12.2.13 IONTOPATCH 276
12.3 CDMO PLAYERS 277
12.3.1 TAPECON, INC. 277
12.3.2 LINXENS 278
12.3.3 QUAD INDUSTRIES 279
12.3.4 BENELI.COM 280
12.3.5 HI-TECH PRODUCTS 281
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
13 APPENDIX 282
13.1 INSIGHTS FROM INDUSTRY EXPERTS 282
13.2 DISCUSSION GUIDE 283
13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 287
13.4 CUSTOMIZATION OPTIONS 289
13.5 RELATED REPORTS 289
13.6 AUTHOR DETAILS 290